Search

Too many initiatives in the European Union are blunted by lack of clarity. That can’t happen with cluster policy, says the Science|Business Innovation Board.

Cambridge, Mass., is acknowledged as one of the leading biotech clusters. The question now: how to maintain that edge in the face of global competition.

Even one of the best-known super clusters must take steps to remain stable and sustainable as new competitors arise at home and abroad.

After the proposed Small Business Act, now it’s the turn of the European Commission’s wealthiest department – the regional policy directorate – to do its bit for SMEs.

The industry body France Biotech has changed its statutes of association to allow innovative life science companies to be more widely represented.

The UK’s National Physical Laboratory is to coordinate a consortium looking at materials and process to control the environmental impact of engineered products.

The technology commercialisation firm Braveheart is to have exclusive first right of refusal on Aberdeen University’s IP for the next 15 years.

Ireland’s inward investment arm, IDA Ireland, gave an upbeat and positive message in its review of 2007 – despite challenging global economic circumstances.

Albania has moved closer to membership of the European Union, signing up to the entrepreneurship and innovation arm of the EU’s programme for SMEs.